Reports for NALTREXONE HYDROCHLORIDE
Ingredient
NALTREXONE HYDROCHLORIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| REVIA | 50MG | TABLET | Resolved | 2024-01-11 | 2024-02-13 | 215710 |
| CONTRAVE | 90MG 8MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2024-02-01 | 2024-02-05 | 218165 |
| REVIA | 50MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190707 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2023-01-06 | 2023-03-30 | 180119 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-08-13 | 2021-08-31 | 144142 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-05-28 | 2021-07-09 | 140075 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-02-12 | 2021-03-15 | 133991 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2020-04-06 | 2020-05-04 | 111060 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2019-08-07 | 2019-08-19 | 91091 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2018-11-21 | 2019-02-01 | 67404 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0